Home » Topics » BioWorld Science

BioWorld Science
RSS

Tempest Therapeutics divulges IDO1 inhibitors

May 10, 2019

eFFECTOR Therapeutics describes MNK1 and MNK2 inhibitors

May 10, 2019

Epizyme discloses EHMT1 and/or EHMT2 inhibitors

May 10, 2019

Incyte patents PI3Kgamma inhibitors

May 10, 2019

Bristol-Myers Squibb presents new hSTING agonists

May 10, 2019

CAR T-cell therapy targeting AMHR2, a potential treatment for ovarian cancer

May 10, 2019

First clinical results on K-0706 presented as potential treatment for Parkinson's disease

May 10, 2019

Nintedanib ophthalmic nanosuspension tested in animal model as pterygium treatment

May 10, 2019

resTORbio initiates phase III program of RTB-101 in clinically symptomatic respiratory illness

May 10, 2019

CheckMate498 phase III study of Opdivo does not meet primary endpoint

May 10, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...